Quoin pharmaceuticals to initiate clinical study for peeling skin syndrome

Peeling skin syndrome is a rare autosomal disease with no approved treatment or cure initial clinical site and pediatric patient identified in new zealand company actively evaluating opening additional clinical sites in other countries ashburn, va., aug. 06, 2024 (globe newswire) -- quoin pharmaceuticals ltd.
QNRX Ratings Summary
QNRX Quant Ranking